JP2006213732A5 - - Google Patents

Download PDF

Info

Publication number
JP2006213732A5
JP2006213732A5 JP2006134026A JP2006134026A JP2006213732A5 JP 2006213732 A5 JP2006213732 A5 JP 2006213732A5 JP 2006134026 A JP2006134026 A JP 2006134026A JP 2006134026 A JP2006134026 A JP 2006134026A JP 2006213732 A5 JP2006213732 A5 JP 2006213732A5
Authority
JP
Japan
Prior art keywords
group
substituent
acyl
carbamoyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006134026A
Other languages
English (en)
Japanese (ja)
Other versions
JP4505753B2 (ja
JP2006213732A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2006134026A priority Critical patent/JP4505753B2/ja
Priority claimed from JP2006134026A external-priority patent/JP4505753B2/ja
Publication of JP2006213732A publication Critical patent/JP2006213732A/ja
Publication of JP2006213732A5 publication Critical patent/JP2006213732A5/ja
Application granted granted Critical
Publication of JP4505753B2 publication Critical patent/JP4505753B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006134026A 2000-12-01 2006-05-12 ラクタム化合物及びその医薬用途 Expired - Fee Related JP4505753B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006134026A JP4505753B2 (ja) 2000-12-01 2006-05-12 ラクタム化合物及びその医薬用途

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000367175 2000-12-01
JP2006134026A JP4505753B2 (ja) 2000-12-01 2006-05-12 ラクタム化合物及びその医薬用途

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2002546550A Division JP3826400B2 (ja) 2000-12-01 2001-11-29 ラクタム化合物及びその医薬用途

Publications (3)

Publication Number Publication Date
JP2006213732A JP2006213732A (ja) 2006-08-17
JP2006213732A5 true JP2006213732A5 (cg-RX-API-DMAC7.html) 2007-02-22
JP4505753B2 JP4505753B2 (ja) 2010-07-21

Family

ID=18837660

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002546550A Expired - Lifetime JP3826400B2 (ja) 2000-12-01 2001-11-29 ラクタム化合物及びその医薬用途
JP2006134026A Expired - Fee Related JP4505753B2 (ja) 2000-12-01 2006-05-12 ラクタム化合物及びその医薬用途

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2002546550A Expired - Lifetime JP3826400B2 (ja) 2000-12-01 2001-11-29 ラクタム化合物及びその医薬用途

Country Status (26)

Country Link
US (3) US7153850B2 (cg-RX-API-DMAC7.html)
EP (1) EP1346993B1 (cg-RX-API-DMAC7.html)
JP (2) JP3826400B2 (cg-RX-API-DMAC7.html)
KR (1) KR100826818B1 (cg-RX-API-DMAC7.html)
CN (2) CN1269818C (cg-RX-API-DMAC7.html)
AT (1) ATE446297T1 (cg-RX-API-DMAC7.html)
AU (3) AU1850202A (cg-RX-API-DMAC7.html)
BG (1) BG107857A (cg-RX-API-DMAC7.html)
BR (1) BR0115852A (cg-RX-API-DMAC7.html)
CA (1) CA2430124C (cg-RX-API-DMAC7.html)
CZ (1) CZ20031520A3 (cg-RX-API-DMAC7.html)
DE (1) DE60140270D1 (cg-RX-API-DMAC7.html)
ES (1) ES2331299T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0400806A3 (cg-RX-API-DMAC7.html)
IL (1) IL156158A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03004876A (cg-RX-API-DMAC7.html)
NO (1) NO325401B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ526164A (cg-RX-API-DMAC7.html)
PL (1) PL362835A1 (cg-RX-API-DMAC7.html)
RU (1) RU2287530C2 (cg-RX-API-DMAC7.html)
SK (1) SK6582003A3 (cg-RX-API-DMAC7.html)
TW (1) TWI241302B (cg-RX-API-DMAC7.html)
UA (1) UA76969C2 (cg-RX-API-DMAC7.html)
WO (1) WO2002044180A1 (cg-RX-API-DMAC7.html)
YU (1) YU42603A (cg-RX-API-DMAC7.html)
ZA (1) ZA200304100B (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI241302B (en) * 2000-12-01 2005-10-11 Ajinomoto Kk Lactam compounds and pharmaceutical use thereof
MXPA05008363A (es) 2003-02-07 2005-12-06 Ajinomoto Kk Agentes terapeuticos para diabetes.
WO2005042536A1 (ja) * 2003-10-31 2005-05-12 Ajinomoto Co., Inc. 複素環を有する新規縮合多環式化合物及びその医薬用途
CA2553329A1 (en) 2004-01-14 2005-07-28 Ajinomoto Co., Inc. New fused polycyclic compounds
CN101899049A (zh) * 2004-10-13 2010-12-01 霍夫曼-拉罗奇有限公司 二取代吡唑并苯并二氮杂*类
JP5056412B2 (ja) 2005-04-28 2012-10-24 味の素株式会社 新規ラクタム化合物
EP2157092A4 (en) * 2007-04-11 2011-04-13 Ajinomoto Kk Remedy for diabetes
WO2008136394A1 (ja) * 2007-04-27 2008-11-13 Ajinomoto Co., Inc. ラクタム化合物の製造方法及びその製造中間体
WO2008139574A1 (ja) * 2007-04-27 2008-11-20 Ajinomoto Co., Inc. ラクタム化合物の結晶形およびその製造方法
WO2008139575A1 (ja) * 2007-04-27 2008-11-20 Ajinomoto Co., Inc. 経口投与用製剤
CN101619041B (zh) * 2008-07-02 2012-07-04 重庆华邦制药股份有限公司 一种二酮基含氮环化合物的合成方法及其中间体
JP2012180283A (ja) * 2009-07-02 2012-09-20 Ajinomoto Co Inc ラクタム化合物の製造方法およびその製造中間体
JP2012180282A (ja) * 2009-07-02 2012-09-20 Ajinomoto Co Inc ラクタム化合物の製造方法およびその製造中間体
EP3238723B1 (en) * 2014-12-22 2020-02-05 EA Pharma Co., Ltd. Drug for treating disorders of corneal epithelium
WO2017127306A1 (en) 2016-01-18 2017-07-27 Arisan Therapeutics Adamatane derivatives for the treatment of filovirus infection
US11548893B2 (en) 2017-07-15 2023-01-10 Arisan Therapeutics Inc. Enantiomerically pure adamantane carboxamides for the treatment of filovirus infection
TWI820289B (zh) * 2019-01-23 2023-11-01 醣解生醫股份有限公司 β-內醯胺類化合物或其鹽於長效預防或治療葡萄糖代謝失調之用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US48847A (en) * 1865-07-18 Improvement in vessels for reception and transportation of night-soil
US189597A (en) * 1877-04-17 Improvement in portable wash-stands
GB8720414D0 (en) * 1987-08-28 1987-10-07 Roussel Lab Ltd Chemical compounds
US5719296A (en) * 1995-10-30 1998-02-17 Merck & Co., Inc. Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins
ES2229523T3 (es) 1997-07-30 2005-04-16 Wyeth Agonistas triciclicos de la vasopresina.
JP4204657B2 (ja) 1997-12-05 2009-01-07 有限会社ケムフィズ 糖尿病の予防・治療剤
TWI241302B (en) * 2000-12-01 2005-10-11 Ajinomoto Kk Lactam compounds and pharmaceutical use thereof
MXPA05008363A (es) * 2003-02-07 2005-12-06 Ajinomoto Kk Agentes terapeuticos para diabetes.

Similar Documents

Publication Publication Date Title
Zhang et al. New progress in azole compounds as antimicrobial agents
DeGoey et al. Discovery of pyrido [2, 3-d] pyrimidine-based inhibitors of HCV NS5A
Li et al. Discovery of (R)-6-cyclopentyl-6-(2-(2, 6-diethylpyridin-4-yl) ethyl)-3-((5, 7-dimethyl-[1, 2, 4] triazolo [1, 5-a] pyrimidin-2-yl) methyl)-4-hydroxy-5, 6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor
JP2008044952A5 (cg-RX-API-DMAC7.html)
JP2010526814A5 (cg-RX-API-DMAC7.html)
GEP201706611B (en) Amido compounds and their use as pharmaceuticals
JP2007510662A5 (cg-RX-API-DMAC7.html)
JP2009514837A5 (cg-RX-API-DMAC7.html)
JP2011519854A5 (cg-RX-API-DMAC7.html)
JP2008533191A5 (cg-RX-API-DMAC7.html)
WO2008126901A1 (ja) 含窒素複素環化合物およびそれを含有する医薬組成物
WO2009010416A3 (en) Inhibitors of 11b-hydroxysteroid dehydrogenase
WO2007082808A3 (en) Thiazoles as 11 beta-hsd1 inhibitors
WO2007060140A3 (en) Inhibitors of diacyglycerol acyltransferase (dgat)
MY159203A (en) Solid preparation comprising alogliptin and metformin hydrochloride
CA2683059A1 (en) Atropisomer of pyrrole derivative
NO20092033L (no) Nye forbindelser
WO2005044192A3 (en) Triazole compounds and uses related thereto
JP2009514835A5 (cg-RX-API-DMAC7.html)
JP2011520906A5 (cg-RX-API-DMAC7.html)
MX2007010532A (es) Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii.
JP2010501478A5 (cg-RX-API-DMAC7.html)
WO2010003624A3 (en) Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
DE602006009095D1 (en) Diacylglycerol-acyltransferase-hemmer
JP2010527980A5 (cg-RX-API-DMAC7.html)